Bionano Genomics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Similarly, Is BNGO a good buy?
Based on his analysis, DeGeeter rates BNGO stock as « outperform » with a $14 value. Other analysts are also bullish on the company. Those tracked by the Wall Street Journal have BNGO rated as a consensus « buy » with an average $12 price target.
Will BNGO get FDA approval? The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.
Thereof, What does BNGO company do?
Company Description
The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
What does BNGO make?
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis.
Is BNGO expected to rise?
Bionano Genomics Inc (NASDAQ:BNGO)
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +253.77% increase from the last price of 2.12.
Is BNGO a meme stock?
Admittedly, it has been a while since Bionano Genomics (NASDAQ:BNGO) stock has been a “hot stock,” a “meme stock” or whatever you want to call it. Since its big drop in late February and early March, the market has had mixed feelings about this life sciences company.
Who owns Bionano genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Is BNGO a US stock?
BNGO:USNASDAQ CM. Bionano Genomics Inc.
What kind of stock is BNGO?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.
What is Nio price target?
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.94, with a high estimate of 86.57 and a low estimate of 24.08. The median estimate represents a +67.62% increase from the last price of 19.65.
What type of stock is BNGO?
Common Stock (BNGO)
Does Cathie own BNGO?
Is Cathie Wood Invested in BNGO? As of the time of this writing, it does not appear that Cathie Wood or ARK are invested in Bionano Genomics. The firm’s genomics and biomedical ETF, ARKG, currently contains 52 individual holdings.
What institutions are buying BNGO?
Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 2/14/2022 | Nuveen Asset Management LLC | 0.357% |
| 2/14/2022 | Barclays PLC | 0.123% |
| 2/14/2022 | GSA Capital Partners LLP | 0.019% |
| 2/14/2022 | Mutual Advisors LLC | 0.017% |
Where is BNGO located?
The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
What sector is BNGO in?
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space.
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
How high does IDEX go?
IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
What is the short interest in BNGO?
Bionano Genomics currently has a short interest ratio of 5.0.
Who owns the most NIO stock?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| Baillie Gifford & Co. | 5.76% | 88,858,365 |
| BlackRock Fund Advisors | 2.60% | 40,093,147 |
| The Vanguard Group, Inc. | 2.40% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.13% | 32,887,731 |
How popular is NIO in China?
Shanghai-based Nio was founded in 2014 by William Li, a billionaire entrepreneur who got rich selling services to the auto industry. Nio currently sells three models and has a fourth on the way for early 2022. It’s delivered some 140,000 cars to customers in China and is expanding to Europe.
How far can a NIO car go on one charge?
Not the standard 75-kWh one, mind you, or the 100-kWh long range pack. The killer here is a 150-kWh « ultra long range » battery pack that Nio says enables a range « over 1,000 km » (620 miles).
Join TheMoney.co community and don’t forget to share this post !
